1-(4-Bromophenyl)-3,5-dimethyl-1H-pyrazole, 95.0%, 5g

3-(Boc-Amino)benzoic acid, 95.0%, 10g

1-(1H-1,2,3-triazol-5-yl)methanamine hydrochloride, 95%, 500mg

Sodium hydroxide solution 20%, extra pure, 1 l, plastic packaging.

Fmoc-D-Arg(pbf)-OH, 95%, 25g

2,3-Difluoro-6-nitrophenol, 98.0%, 100g

2-(3-Fluoropyridin-2-yl)-2-methylpropanoic acid, 97.0%, 250mg

{4H,5H,6H,7H-pyrazolo[1,5-a]pyrazin-2-yl}methanol, 97%, 10g

3-Bromo-6-methylpyrazolo[1,5-a]pyrimidine, 97%, 1g

3,5-Difluoro-4-(trifluoromethyl)benzaldehyde, 97.0%, 1g

Butyl 2-[[3-(Trifluoromethyl)phenyl]amino]benzoate>98.0%(HPLC)(N)200mg

tert-Butyl 2-bromo-6,7-dihydro-5H-imidazo[1,2-a][1,4]diazepine-8(9H)-carboxylate, 97%, 100mg

3-Chloro-4,5-dihydroxybenzoic acid, 95.0%, 5g